Overview

Raised to Date: Raised: $202,770

Deal Terms

Investment Momentum

Company Profile

Deal Summary

Financials

Total Commitments ($USD)

Platform

Netcapital

Start Date

09/24/2020

Close Date

03/24/2021

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF / RegD 506(c)    

Price Per Share

$5.00

Pre-Money Valuation

$20,000,000

Rolling Commitments ($USD)

Status

Funded

Reporting Date

03/30/2021

Days Remaining

Funded

% of Min. Goal

Funded

% of Max. Goal

Funded

Likelihood of Max

Funded

Avg. Daily Raise

$1,127

Momentum

Funded

Create a free account today to gain access to KingsCrowd analytics.

Logos provided by Clearbit

Vymedic

Year Founded

2020

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2C

Margin

High

Capital Intensity

High

Location

Englewood, Colorado

Business Type

Growth

Company Website

Vymedic, with a post-money valuation of $23 million, is raising crowdfunding on NetCapital. The company has manufactured Vymune, a broad-spectrum antiviral, that beats other treatments in the suppression of influenza. Vymune is not strain-specific and activates the immune system against the illness. Cynthia Winning founded Vymedic in March 2020. The current crowdfunding round has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for hiring, manufacturing, and marketing. The product of Vymedic is patented, natural, and made up of amino acids, bioflavonoids, and co-factors. It is safe to use for children, elderly, pregnant women, and immunosuppressed individuals.

Summary Profit and Loss Statement

	Most Recent Year	Prior Year
Revenue	$0	$0
COGS	$0	$0
Tax	$0	$0
Net Income	$-46,788	$-45,688

Summary Balance Sheet

	Most Recent Year	Prior Year
Cash	$2,032	$3,105
Accounts Receivable	$0	$0
Total Assets	$2,032	$3,105
Short-Term Debt	$0	$0
Long-Term Debt	$0	$0
Total Liabilities	$0	$0

Financials as of: 09/24/2020

Create a free account today to gain access to KingsCrowd analytics.

Vymedic Founder Cynthia Winning on Antiviral Solutions

In the age of COVID-19, broad-spectrum, OTC, antivirals could change the game. Under the leadership of Cynthia Winning, the team at Vymedic is aiming to disrupt the OTC wellness space with a new immune support tablet. We sat down with Cynthia to discuss what inspired her to build the company, her vision for the future of the space, and more-

Read Founder Interview